Showing 261 - 280 results of 336 for search '"Class I MHC"', query time: 1.36s Refine Results
  1. 261

    Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction by Zita Kruize, Ad C. van Nuenen, Stan W. van Wijk, Arginell F. Girigorie, Karel A. van Dort, Thijs Booiman, Neeltje A. Kootstra

    Published 2021-03-01
    “…Nef is a multifunctional viral protein that has the ability to downregulate cell surface molecules, including CD4 and major histocompatibility complex class I (MHC-I) and, as recently shown, also members of the serine incorporator family (SERINC). …”
    Get full text
    Article
  2. 262

    Improved prediction of MHC-peptide binding using protein language models by Nasser Hashemi, Boran Hao, Mikhail Ignatov, Mikhail Ignatov, Ioannis Ch. Paschalidis, Ioannis Ch. Paschalidis, Ioannis Ch. Paschalidis, Pirooz Vakili, Sandor Vajda, Sandor Vajda, Sandor Vajda, Dima Kozakov, Dima Kozakov, Dima Kozakov

    Published 2023-08-01
    “…Major histocompatibility complex Class I (MHC-I) molecules bind to peptides derived from intracellular antigens and present them on the surface of cells, allowing the immune system (T cells) to detect them. …”
    Get full text
    Article
  3. 263

    A broadened HLA ligandome uncovers new immunotherapy targets for pancreatic cancer + A prime editor mouse to model a broad spectrum of somatic mutations by Ely, Zackery A.

    Published 2023
    “…A subset of tumors is computationally predicted to harbor potentially immunogenic peptides for MHC class I (MHC-I) presentation, but the nature, expression, and immunogenicity of these peptides has yet to be determined. …”
    Get full text
    Thesis
  4. 264

    IFN-τ Mediated Control of Bovine Major Histocompatibility Complex Class I Expression and Function via the Regulation of bta-miR-148b/152 in Bovine Endometrial Epithelial Cells by Haichong Wu, Kangfeng Jiang, Shuai Guo, Jing Yang, Gan Zhao, Changwei Qiu, Ganzhen Deng

    Published 2018-02-01
    “…IFN-τ, a type I interferon produced by the trophoblasts of ruminants, has various important immune functions, including effects on the expression of major histocompatibility complex (MHC) class I (MHC-I). A previous study has reported that IFN-τ promotes the expression of MHC-I molecules on endometrial cells. …”
    Get full text
    Article
  5. 265

    Pathologic characterization of white striping myopathy in broiler chickens by Francesco Prisco, Davide De Biase, Giuseppe Piegari, Ilaria d'Aquino, Adriano Lama, Federica Comella, Raffaelina Mercogliano, Ludovico Dipineto, Serenella Papparella, Orlando Paciello

    Published 2021-07-01
    “…There was diffuse sarcoplasmic and sarcolemmal overexpression of the major histocompatibility complex class I (MHC I). The severity of the histologic lesions was positively correlated with the macroscopic degree of white striations. …”
    Get full text
    Article
  6. 266

    Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism by Xiaohui Wei, Song Wang, Zhuolin Li, Zibin Li, Zehui Qu, Suqiu Wang, Baohua Zou, Ruiying Liang, Chun Xia, Chun Xia, Nianzhi Zhang

    Published 2021-02-01
    “…The micropolymorphism of major histocompatibility complex class I (MHC-I) can greatly alter the plasticity of peptide presentation, but elucidating the underlying mechanism remains a challenge. …”
    Get full text
    Article
  7. 267

    Improved haplotype resolution of highly duplicated MHC genes in a long-read genome assembly using MiSeq amplicons by Samantha Mellinger, Martin Stervander, Max Lundberg, Anna Drews, Helena Westerdahl

    Published 2023-07-01
    “…Single exons, representing MHC class I (MHC-I) and class IIB (MHC-IIB) alleles, were sequenced in the focal individual and mapped to the annotated MHC alleles in the original long-read genome assembly. …”
    Get full text
    Article
  8. 268

    Characterization of the peripheral blood transcriptome and adaptive evolution of the MHC I and TLR gene families in the wolf (Canis lupus) by Guangshuai Liu, Honghai Zhang, Guolei Sun, Chao Zhao, Shuai Shang, Xiaodong Gao, Tian Xia, Xiufeng Yang

    Published 2017-08-01
    “…In this study, the peripheral blood transcriptome of wolves was generated via RNA-seq to advance understanding of the wolf immunome, with a special focus on the major histocompatibility complex class I (MHC I) and toll-like receptor (TLR) gene families, which are involved in pathogen recognition and defense. …”
    Get full text
    Article
  9. 269

    Transcriptome Analysis Shows That IFN-I Treatment and Concurrent SAV3 Infection Enriches MHC-I Antigen Processing and Presentation Pathways in Atlantic Salmon-Derived Macrophage/De... by Cheng Xu, Øystein Evensen, Hetron Mweemba Munang’andu

    Published 2019-05-01
    “…We found that concurrent treatment of TO-cells with IFN-I and SAV3 infection (SAV3/IFN<sup>+</sup>) significantly enriched the major histocompatibility complex class I (MHC-I) pathway unlike the non-IFN-I treated TO-cells (SAV3/IFN<sup>&#8722;</sup>) that had lower expression levels of MHC-I pathway-related genes. …”
    Get full text
    Article
  10. 270

    NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity by Madanraj Appiya Santharam, Akhil Shukla, Dominique Levesque, Thomas A. Kufer, François-Michel Boisvert, Sheela Ramanathan, Subburaj Ilangumaran

    Published 2023-04-01
    “…Aggressive tumors evade cytotoxic T lymphocytes by suppressing MHC class-I (MHC-I) expression that also compromises tumor responsiveness to immunotherapy. …”
    Get full text
    Article
  11. 271

    Identification of prognostic and bone metastasis​‐related alternative splicing signatures in mesothelioma by Runzhi Huang, Zixuan Zheng, Sijia Liu, Penghui Yan, Dianwen Song, Huabin Yin, Peng Hu, Xiaolong Zhu, Zhengyan Chang, Yihan Liu, Juanwei Zhuang, Tong Meng, Zongqiang Huang, Jie Zhang

    Published 2021-07-01
    “…Finally, we proposed that splicing factor (SF) HSPA1A could regulate SNX5‐58744‐AT (R = −0.414) and SNX5‐58745‐AT (R = 0.414) through the pathway “Class I MHC mediated antigen processing and presentation” (R = 0.400). …”
    Get full text
    Article
  12. 272

    Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity by Arnika K. Wagner, Ulf Gehrmann, Stefanie Hiltbrunner, Valentina Carannante, Thuy T. Luu, Tanja I. Näslund, Hanna Brauner, Nadir Kadri, Klas Kärre, Susanne Gabrielsson

    Published 2021-01-01
    “…Natural killer (NK) cells can kill target cells via the recognition of stress molecules and down-regulation of major histocompatibility complex class I (MHC-I). Some NK cells are educated to recognize and kill cells that have lost their MHC-I expression, e.g., tumor or virus-infected cells. …”
    Get full text
    Article
  13. 273
  14. 274

    Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment by Hong Zhou, Hong Zhou, Hong Zhou, Yipeng Ma, Yipeng Ma, Fenglan Liu, Fenglan Liu, Bin Li, Bin Li, Dongjuan Qiao, Dongjuan Qiao, Peigen Ren, Mingjun Wang, Mingjun Wang

    Published 2023-09-01
    “…Cancer vaccines, an important element of cancer immunotherapy, function by presenting an exogenous source of TAA proteins, peptides, and antigenic epitopes to CD4+ T cells via major histocompatibility complex class II (MHC-II) and to CD8+ T cells via major histocompatibility complex class I (MHC-I). These mechanisms further enhance the immune response against TAAs mediated by cytotoxic T lymphocytes (CTLs) and helper T cells. …”
    Get full text
    Article
  15. 275

    Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma by Elena Shklovskaya, Jenny H Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter Ferguson, Robyn PM Saw, John F Thompson, Brindha Shivalingam, Matteo S Carlino, Richard A Scolyer, Alexander M Menzies, Georgina V Long, Richard F Kefford, Helen Rizos

    Published 2020-11-01
    “…A novel quantitative score was developed to determine the tumor cell expression of antigen-presenting MHC class I (MHC-I) molecules, and to correlate expression data with treatment response. …”
    Get full text
    Article
  16. 276

    ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection by Yuyu Li, Guangzhi Wang, Xiaoxiu Tan, Jian Ouyang, Menghuan Zhang, Xiaofeng Song, Qi Liu, Qibin Leng, Lanming Chen, Lu Xie

    Published 2020-04-01
    “…Results Here we report the construction of proteogenomics prediction of neoantigen (ProGeo-neo) pipeline, which incorporates the following modules: mining tumor specific antigens from next-generation sequencing genomic and mRNA expression data, predicting the binding mutant peptides to class I MHC molecules by latest netMHCpan (v.4.0), verifying MHC-peptides by MaxQuant with mass spectrometry proteomics data searched against customized protein database, and checking potential immunogenicity of T-cell-recognization by additional screening methods. …”
    Get full text
    Article
  17. 277

    Rhoptry and Dense Granule Secreted Effectors Regulate CD8+ T Cell Recognition of Toxoplasma gondii Infected Host Cells by Leah M. Rommereim, Barbara A. Fox, Kiah L. Butler, Viviana Cantillana, Gregory A. Taylor, Gregory A. Taylor, David J. Bzik

    Published 2019-09-01
    “…Here, we investigated the role of parasite-secreted effectors in regulating host access to parasitophorous vacuole (PV) localized parasite antigens and their presentation to CD8+ T cells by the major histocompatibility class I (MHC-I) pathway. Antigen presentation of PV localized parasite antigens by MHC-I was significantly increased in macrophages and/or dendritic cells infected with mutant parasites that lacked expression of secreted GRA (GRA2, GRA3, GRA4, GRA5, GRA7, GRA12) or ROP (ROP5, ROP18) effectors. …”
    Get full text
    Article
  18. 278
  19. 279

    BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression by Frank Nestle, Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, Tsuri Peretz, Dror Alishekevitz, Anna Fridman Dror, Motti Hakim, Sharon Hashmueli, Itay Friedman, Yair Sapir, Rita Greco, Hongjing Qu, Dmitri Wiederschain, Lily Pao, Sharad Sharma, Tehila Ben Moshe

    Published 2022-09-01
    “…In the tumor microenvironment, binding of class I MHC (in particular HLA-G) to ILT2 on immune cells mediates a strong inhibitory effect, which manifests in inhibition of antitumor cytotoxicity of T and NK cells, and prevention of phagocytosis of the tumor cells by macrophages.Methods We describe here the development and characteristics of BND-22, a novel, humanized monoclonal antibody that selectively binds to ILT2 and blocks its interaction with classical MHC I and HLA-G. …”
    Get full text
    Article
  20. 280